| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 2 | Clozapine | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 3 | Oxcarbazepine | FAERS: 1 | US FAERS | |
| 4 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 5 | Trimethoprim, Sulfamethoxazole Drug Combination | FAERS: 1 | US FAERS | |
| 6 | Leucovorin | OFFSIDES | ||
| 7 | Maloprim | OFFSIDES | ||
| 8 | Nefopam | OFFSIDES | ||
| 9 | Pamidronate | OFFSIDES | ||
| 10 | Sulfadiazine | OFFSIDES | ||
| 11 | Tamoxifen | OFFSIDES | ||
| 12 | Tazobactam | OFFSIDES | ||
| 13 | efavirenz | OFFSIDES | ||
| 14 | fludarabine phosphate | OFFSIDES | ||
| 15 | fludarabine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.